ESTRO 35 2016 S871 ________________________________________________________________________________ patients with high-risk extremity soft tissue sarcoma. A twotier registration was used to align the tumor VOI within each dynamic frame at TP1 and align the volumes at TP2 to the volumes at TP1. After registration, the voxel-wise transfer constant K trans within a VOI covering the whole tumor normalized to a reference region of normal tissue area closed to the tumor was calculated. The responder threshold was determined by linear regression via evaluating the 95% confidence interval [-T, T] in the residuals from the reference region. The difference of the voxel-wise ΔK trans within the tumor between TP1 and TP2 was calculated. Three classes of voxels within the tumor VOI were determined: voxels having ΔK trans value exceed threshold T were designated in red, below -T were designated in blue, and otherwise designated in green indicating no significant change. The volume fractions with respect to three subvolumes of the tumor VOI were computed as F+ (red voxels), F-(blue voxels) and F0 (green voxels).
Purpose or Objective: Biological behavior differs between histologies of non-small cell lung cancer (NSCLC) . Tumour biology and glucose metabolism influence radiosensitivity. The first goal of this study is to calculate glucose metabolic rate constants k1 (glucose transporter (GLUT) influx), k2 (GLUT efflux), k3 (hexokinase phosphorylation) and blood volume (VB) in adeno-versus squamous cell NSCLC using dynamic 18FDG PET. Heterogeneity of these parameters will be assessed within different tumour regions. This will improve understanding tumour biology and potentially form the basis for dose modifications in radiotherapy. Besides 18FDG PET as a tool indicating radioresistant tumour areas, PET may be used for tumour delineation in radiotherapy planning. Manual tumor delineation of stage III NSCLC for radiotherapy planning takes a lot of effort. The second objective of this study is to correlate tumour dimensions obtained by thresholds of standardized uptake value (SUV; static PET), metabolic rate of glucose (MRglu; dynamic PET) with pathological data. The most appropriate method may quicken tumour delineation for radiotherapy planning.
Material and Methods:
Patients with curatively resected NSCLC were included in this prospective study (n= 35). Dynamic 18FDG-PET scans were acquired during 60 minutes. Patlak analyses using the data acquired between 15-60 minutes post-injection were performed to calculate parametric images of MRglu. The last time frame was used as static PET scan. Tumour volumes were delineated using 50% of maximum, 40% of maximum above background and FLAB algorithm. Maximum SUV (SUVmax) and maximum MRglu (MRglu;max) were calculated. In on-going analysis, volumes acquired by the segmentation methods are correlated with pathology volumes to determine the optimal delineation method for NSCLC. Within the most appropriate method, pharmacokinetic rate constants k1, k2, k3, VB are currently being calculated using an irreversible two-compartment model.
Results
: Initial results showed that SUVmax was higher in squamous cell NSCLCs versus adenocarcinomas (median 17.8 (9-33) versus 11.6 (6-32) respectively, p= 0.002). Also the MRglu;max was higher in squamous cell carcinomas (median 462.6 nanomol/min/g (266.4-1366. 2) versus 301.5 (129.7-1096.5) respectively, p=0.004). Static volumes were larger compared to the dynamic volumes (p<0.001). Applying FLAB algorithm on static PET resulted in the largest volumes (p<0.001).
Conclusion:
These preliminary data support differences in glucose metabolism between adeno-and squamous cell NSCLC. In the ongoing analyses, metabolic rates of glucose will be studied in more detail and will be correlated to survival. Furthermore, tumour volumes acquired by several segmentation methods will be correlated with pathology volumes to determine the optimal delineation method. This optimal segmentation method may aid in radiotherapy delineation. 
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